Search

Haring, White, Kahn, Kasuga, Lauris, Fleischmann, Murray, and Pawelek. 1984. “Abnormality of Insulin Binding and Receptor Phosphorylation in an Insulin-Resistant Melanoma Cell Line”. J Cell Biol 99 (3): 900-8.

Kahn. 1984. “A Proposed New Role for the Insurance Industry in Biomedical Research Funding”. N Engl J Med 310 (4): 257-8.

Grigorescu, White, and Kahn. 1983. “Insulin Binding and Insulin-Dependent Phosphorylation of the Insulin Receptor Solubilized from Human Erythrocytes”. J Biol Chem 258 (22): 13708-16.

Crettaz, and Kahn. 1983. “Analysis of Insulin Action Using Differentiated and Dedifferentiated Hepatoma Cells”. Endocrinology 113 (4): 1201-9.

Blackshear, Rotner, Kriauciunas, and Kahn. 1983. “Reactive Hypoglycemia and Insulin Autoantibodies in Drug-Induced Lupus Erythematosus”. Ann Intern Med 99 (2): 182-4.

Harmon, Hedo, and Kahn. 1983. “Characterization of a Membrane Regulator of Insulin Receptor Affinity”. J Biol Chem 258 (11): 6875-81.

Taniguchi, Cullen, José Alemán, Kohjiro Ueki, Ji Luo, Tomoichiro Asano, Hideaki Kaneto, Gregory Stephanopoulos, Lewis Cantley, and Ronald Kahn. 2007. “The P85alpha Regulatory Subunit of Phosphoinositide 3-Kinase Potentiates C-Jun N-Terminal Kinase-Mediated Insulin Resistance”. Mol Cell Biol 27 (8): 2830-40.

Biddinger, Sudha, Katrine Almind, Makoto Miyazaki, Efi Kokkotou, James Ntambi, and Ronald Kahn. 2005. “Effects of Diet and Genetic Background on Sterol Regulatory Element-Binding Protein-1c, Stearoyl-CoA Desaturase 1, and the Development of the Metabolic Syndrome”. Diabetes 54 (5): 1314-23.

Katic, and Kahn. 2005. “The Role of Insulin and IGF-1 Signaling in Longevity”. Cell Mol Life Sci 62 (3): 320-43.

Ehrenkranz, Joel, Norman Lewis, Ronald Kahn, and Jesse Roth. 2005. “Phlorizin: a Review”. Diabetes Metab Res Rev 21 (1): 31-8.